UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

Heart (British Cardiac Society), 2009-09, Vol.95 (18), p.1489-1494

2009

Volltextzugriff (PDF)

Recanalization of chronic total coronary occlusion: indications and results

Deutsche medizinische Wochenschrift (1946), 2010-10, Vol.135 (39), p.1931

2010

Volltextzugriff (PDF)

Rekanalisation chronisch verschlossener Koronargefäße: Indikationen und Ergebnisse

Deutsche medizinische Wochenschrift, 2010-10, Vol.135 (39), p.1931-1935

2010

Volltextzugriff (PDF)

Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting

European heart journal, 2007-04, Vol.28 (8), p.968-973

2007

Volltextzugriff (PDF)

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

The Lancet (British edition), 2013-02, Vol.381 (9865), p.461-467

2013

Volltextzugriff (PDF)

Percutaneous Mitral Valve Edge-to-Edge Repair: In-Hospital Results and 1-Year Follow-Up of 628 Patients of the 2011-2012 Pilot European Sentinel Registry

Journal of the American College of Cardiology, 2014-09, Vol.64 (9), p.875-884

2014

Volltextzugriff (PDF)

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

European heart journal, 2015-05, Vol.36 (20), p.1252-1263

2015

Volltextzugriff (PDF)

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial

The Lancet (British edition), 2011-09, Vol.378 (9796), p.1071-1078

2011

Volltextzugriff (PDF)

Abciximab and Heparin versus Bivalirudin for Non–ST-Elevation Myocardial Infarction

The New England journal of medicine, 2011-11, Vol.365 (21), p.1980-1989

2011

Volltextzugriff (PDF)

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

European heart journal, 2014-09, Vol.35 (34), p.2285-2294

2014

Volltextzugriff (PDF)

P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents

Cardiology, 2009-01, Vol.112 (4), p.263-269

2009

Volltextzugriff (PDF)

Interferon-γ and interferon-γ receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting

Atherosclerosis, 2005-09, Vol.182 (1), p.145-151

2005

Volltextzugriff (PDF)

Kardiovaskuläre Vorsorge im Breitensport, ambitionierten Freizeitsport und Wettkampfsport über das 35. Lebensjahr hinaus

Deutsche medizinische Wochenschrift, 2014-10, Vol.139 (43), p.2188-2194

2014

Volltextzugriff (PDF)

Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry

Thrombosis and haemostasis, 2014-12, Vol.112 (6), p.1190-1197

2014

Volltextzugriff (PDF)

Decrease of the norepinephrine release due to disconnection of sympathetic nerves during renal denervation

European heart journal, 2013-08, Vol.34 (suppl 1), p.P565-P565

2013

Volltextzugriff (PDF)

Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting

Cytokine (Philadelphia, Pa.), 2003-11, Vol.24 (4), p.161-171

2003

Volltextzugriff (PDF)

Intracellular Domains of Target Antigens Influence Their Capacity to Trigger Antibody-Dependent Cell-Mediated Cytotoxicity

The Journal of immunology (1950), 2002-04, Vol.168 (7), p.3275-3282

2002

Volltextzugriff (PDF)

The 2011-12 Pilot European Sentinel Registry of Percutaneous Edge-to-Edge Mitral Valve Repair: In-hospital results and mid-term follow up of 587 patients

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, Vol.62 (18), p.B28

2013

Volltextzugriff (PDF)

Intracellular domains of target antigens influence their capacity to trigger ADCC

European journal of cancer (1990), 2001, Vol.37, p.S51-S51

2001

Volltextzugriff (PDF)

Cardiovascular screening for recreational, leisure, vigorous and competitive sport activities over 35 years

Deutsche medizinische Wochenschrift (1946), 2014-10, Vol.139 (43), p.2188

2014

Volltextzugriff (PDF)

Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2710-2716

2010

Volltextzugriff (PDF)

Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients

Catheterization and cardiovascular interventions, 2011-03, Vol.77 (4), p.494-501

2011

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)
Tagungsberichte
(1)

Sprache

Englisch
(18)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

Recanalization of chronic total coronary occlusion: indications and results

Rekanalisation chronisch verschlossener Koronargefäße: Indikationen und Ergebnisse

Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

Percutaneous Mitral Valve Edge-to-Edge Repair: In-Hospital Results and 1-Year Follow-Up of 628 Patients of the 2011-2012 Pilot European Sentinel Registry

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial

Abciximab and Heparin versus Bivalirudin for Non–ST-Elevation Myocardial Infarction

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents

Interferon-γ and interferon-γ receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting

Kardiovaskuläre Vorsorge im Breitensport, ambitionierten Freizeitsport und Wettkampfsport über das 35. Lebensjahr hinaus

Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry

Decrease of the norepinephrine release due to disconnection of sympathetic nerves during renal denervation

Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting

Intracellular Domains of Target Antigens Influence Their Capacity to Trigger Antibody-Dependent Cell-Mediated Cytotoxicity

The 2011-12 Pilot European Sentinel Registry of Percutaneous Edge-to-Edge Mitral Valve Repair: In-hospital results and mid-term follow up of 587 patients

Intracellular domains of target antigens influence their capacity to trigger ADCC

Cardiovascular screening for recreational, leisure, vigorous and competitive sport activities over 35 years

Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study

Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients

Suchergebnisse filtern